Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

NCT05661461 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor, Solid
Tumor
Advanced Solid Tumor

Interventions

DRUG: nab-sirolimus

Sponsor

Aadi Bioscience, Inc.